Hence it will be essential to advance in the knowledge of α7-nAChR as therapeutic target for the treatment of Aβ-induced pathology and AD (Kem, 2000; Chen et al., 2006; Dziewczapolski et al., 2009). The gene discussed is CHRNA7; the disease is Alzheimer disease.